About
Haleon appears at No. 573 in the 2026 Global 2000, a multi-factor ranking based on sales, profits, assets and market value. The company is headquartered in Weybridge, United Kingdom and operates primarily in drugs & biotechnology. Reported figures used for the ranking include $14.5B in sales, $2.2B in profit, $43.9B in assets and a market value of $39.4B.